jueves, 17 de noviembre de 2016

Press Announcements > FDA research to help speed development of Zika virus vaccines and therapeutics

Press Announcements > FDA research to help speed development of Zika virus vaccines and therapeutics



News Release
For Immediate Release:
Nov. 17, 2016
Media Inquiries:
Tara Goodin, 240-402-3157, tara.goodin@fda.hhs.gov
Lauren Smith Dyer, 301-348-1888, lauren.smith2@fda.hhs.gov
Consumer Inquiries:
888-INFO-FDA

FDA research to help speed development of Zika virus vaccines and therapeutics
Neonatal mouse model provides a new platform for Zika virus research
A new mouse model developed by scientists at the U.S. Food and Drug Administration may help in exploring the potential activity of Zika virus vaccines and therapeutics. Published today in PLoS Pathogens, is the description of a neonatal mouse model that provides a platform for potentially improving and expediting studies to understand the causes and effects (pathology) of the Zika virus.

Read more.

No hay comentarios:

Publicar un comentario en la entrada